Real-world (rw) treatment (tx) patterns and clinical outcomes among patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line (1L) systemic tx and avelumab 1L maintenance (1LM): Results from the IMPACT UC-III study.
| Publicado en: | Journal of Clinical Oncology Vol. 42; pp. 390 - 403 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2024 Supplement 10
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180102604&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 180102604 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2024 Supplement 10 vid: 42 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 180102604 10.1200/OP.2024.20.10_suppl.390 180102604 ppf: 390 ppct: 13 formats: tig: atl: Real-world (rw) treatment (tx) patterns and clinical outcomes among patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line (1L) systemic tx and avelumab 1L maintenance (1LM): Results from the IMPACT UC-III study. aug: au: Moon, Helen Ike, Chiemeka Morris, Valerie A. Wangia Dixon, Ruth Tonnu-Mihara, Ivy Crowe, Christopher L. Venkataraman, Malvika Kearney, Mairead Barron, John affil: Southern California Permanente Medical Group, Riverside, CA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|